Intratracheal Budesonide for Extremely Preterm Infants

Intratracheal Budesonide for Extremely Preter...

Suivant

From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo

In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content: Research of the Year 2025 

The Sequential Organ Failure Assessment (SOFA)-2 Score

SOFA-2, validated in more than 3 million intensive care unit (ICU) patients, incorporates contemporary organ support treatments, showing strong predictive validity for ICU mortality in diverse international settings. Coauthor Mervyn Singer, MD, joins JAMA Associate Editor Christo ...  Afficher plus

Épisodes Recommandés

2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
Lungcast

For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ...  Afficher plus

Lung Cancer
Ninja Nerd

Ninja Nerds,
Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we discuss Lung Cancer, a leading cause of cancer-related mortality worldwide. We explore the pathophysiology, risk factors, and key differences between non-small cell lung cancer ...

  Afficher plus

Non-Muscle Invasive Bladder Cancer Basics with Dr. Kyle Richards
Urology Care Podcast

Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ...  Afficher plus

Clinical Challenges in Colorectal Surgery: Early Onset Colorectal Cancer
Behind The Knife: The Surgery Podcast

<div>The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we pr ...  Afficher plus